Dynavax Technologies Corporation
DVAX
$10.31
-$0.34-3.19%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 268.43M | 248.46M | 231.44M | 217.69M | 213.30M |
| Total Other Revenue | 8.82M | 12.35M | 18.26M | 18.46M | 18.99M |
| Total Revenue | 277.25M | 260.81M | 249.70M | 236.15M | 232.28M |
| Cost of Revenue | 108.26M | 98.88M | 98.80M | 98.47M | 102.48M |
| Gross Profit | 168.99M | 161.94M | 150.90M | 137.68M | 129.81M |
| SG&A Expenses | 168.10M | 168.11M | 163.25M | 158.85M | 160.26M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 276.35M | 266.99M | 262.05M | 257.32M | 262.74M |
| Operating Income | 893.00K | -6.18M | -12.36M | -21.17M | -30.45M |
| Income Before Tax | 30.86M | 24.22M | 18.55M | 7.85M | -4.37M |
| Income Tax Expenses | 3.55M | 3.75M | 1.37M | -1.37M | 2.02M |
| Earnings from Continuing Operations | 27.31 | 20.48 | 17.18 | 9.22 | -6.39 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 27.31M | 20.48M | 17.18M | 9.22M | -6.39M |
| EBIT | 893.00K | -6.18M | -12.36M | -21.17M | -30.45M |
| EBITDA | 5.52M | -1.62M | -7.87M | -16.72M | -26.11M |
| EPS Basic | 0.21 | 0.16 | 0.13 | 0.07 | -0.05 |
| Normalized Basic EPS | 0.15 | 0.12 | 0.08 | 0.03 | -0.03 |
| EPS Diluted | 0.18 | 0.13 | 0.11 | 0.06 | -0.06 |
| Normalized Diluted EPS | 0.12 | 0.09 | 0.06 | 0.02 | -0.04 |
| Average Basic Shares Outstanding | 520.20M | 521.63M | 519.49M | 517.19M | 514.92M |
| Average Diluted Shares Outstanding | 592.50M | 572.75M | 572.14M | 569.82M | 567.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |